17 Patents
- US126054592026Protein-drug Conjugates Comprising Camptothecin Analogs and Methods of Use Thereof
REGENERON PHARMACEUTICALS, Inc.
0 cites - 0 cites
- US125839392026Bispecific Antigen Binding Molecules That Bind HER2, and Methods of Use Thereof
REGENERON PHARMACEUTICALS, Inc.
0 cites - 0 cites
- 0 cites
- US123381992025Bis-octahydrophenanthrene Carboxamides and Protein Conjugates Thereof
REGENERON PHARMACEUTICALS, Inc.
0 cites - US122801242025Antibody-drug Conjugates Comprising GLP1 Peptidomimetics and Uses Thereof
REGENERON PHARMACEUTICALS, Inc.
0 cites - US122091802025Bis-octahydrophenanthrene Carboxamide Derivatives and Protein Conjugates Thereof for Use as LXR Agonists
REGENERON PHARMACEUTICALS, Inc.
0 cites - 0 cites
- 0 cites
- 0 cites
- 0 cites
- US119589102024Bispecific Antigen Binding Molecules That Bind HER2, and Methods of Use Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - 0 cites
- US117866032023Optimized Transglutaminase Site-specific Antibody Conjugation
REGENERON PHARMACEUTICALS, Inc.
0 cites - 0 cites
- 0 cites